Houston Cancer Researcher Elected Director Of Lasker Awards Program

Jordan U. Gutterman, chairman of the department of clinical immunology and biological therapy at the University of Texas M.D. Anderson Cancer Center in Houston, has been elected executive vice president of the Albert and Mary Lasker Foundation. Gutterman, whose appointment took effect on the first of the year, will also direct the Albert Lasker Medical Research Awards Program. While honoring scientists has been a primary objective since the Lasker awards were first given in 1944, their role in

Written byRebecca Andrews
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Gutterman maintains that both the media and the scientific community are responsible for disseminating information about science to the public. "We just have to keep writing and keep informing people about this," says Gutterman. "People want to know about [science]. If there is ignorance about this, it's because scientists have not communicated it well enough." Gutterman praises the daily newspapers with science sections, but notes that while nearly every newspaper has a sports section, "relatively few have a regular science section."

Gutterman is known for his work with interferons and other proteins in cancer therapy. In addition to his chairmanship, he is professor of medicine and Virginia H. Cockrell Professor of Clinical Immunology at M.D. Anderson Cancer Center. He earned his M.D. in 1964 from the Medical College of Virginia in Richmond, and joined the faculty of M.D. Anderson in 1971.

The Lasker awards for basic and clinical research have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies